Publication: 4755

Physical activity and molecular residual disease (MRD) in stage III colon cancer: findings from CALGB (Alliance)/SWOG 80702.
      Google Scholar   
Citation:
J Clin Oncol vol 44 (2_suppl) 163
Meeting Instance:
ASCO 2026
Year:
2026
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
4901  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
GU    
Pharmas:
Pfizer, Natera  
Grants:
U10CA180821, U10CA180882, UG1CA189823  
Corr. Author:
 
Authors:
                                                       
Networks:
 
Study
CALGB-80702
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: